英夫利昔治疗二例克罗恩病瘘管的近期疗效  

Efficacy of Infliximab Treatment for Crohn's Disease Fistula

作　　者：孙洁[1] 陈欢[1] 李瑾[1] 林军[1] 夏冰[1] 

机构地区：[1]武汉大学中南医院消化内科湖北省肠病医学临床研究中心,430071

出　　处：《中国消化内镜》2009年第4期33-35,共3页Digestive Disease and Endoscopy

基　　金：湖北省肠病医学临床研究中心IBD专项(2008BCC002);湖北省创新群体项目(2007ABC010)

摘　　要：目的探讨英夫利昔治疗克罗恩病瘘管的近期疗效。方法采用英夫利昔静滴方法,治疗2例克罗恩病瘘管患者46周,随访疗效和不良反应。结果2例克罗恩病患者经英夫利昔诱导缓解并维持治疗46周后,瘘管愈合,未见明显不良反应。结论英夫利昔对克罗恩病瘘管具有良好的近期闭合作用,使用安全。Objective： To study efficacy ofinfliximab treatment for Crohn＇s disease fistula. Methods： Two cases of Crohn＇s disease with fistula were treated with infliximab for 46 weeks by intravenous infusion, and evaluate efficacy and side effects by following the patients. Results： Two cases of Crohn＇s disease fistula were closed with the infliximab treatment for 46 weeks. No side effects were observed during the treatment. Conclusions： Infliximab is effective for fistula of Crohn）s disease and is safe during short term therapy.

关 键 词：英夫利昔 克罗恩病 瘘管 

分 类 号：R574.62[医药卫生—消化系统] R749.3[医药卫生—内科学]